Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges

Robert S Rosenson¹, H Bryan Brewer, Benjamin Ansell+6

• ¹Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (R.S.R.); Cardiovascular Research Institute, MedStar Research Institute, Washington Hospital Center, Washington, DC (H.B.B.); Atherosclerosis Research Unit, Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA (B.A.); Centre for Vascular Research at the University of New South Wales, Sydney, Australia (P.B.); Dyslipidemia, Atherosclerosis and Inflammation Research Unit 939, National Institute for Health and Medical Research, University of Pierre and Marie Curie - Paris 6, Pitie-Salpetriere Hospital, Paris, France (M.J.C., A.K.) Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle (J.W.H.); Department of Medicine, Columbia University, New York, NY (A.R.T.); and Internal Medicine and Saha Cardiovascular Research Center, University of Kentucky College of Medicine, Lexington (N.R.W.).